Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Evrosina I. Isaac"'
Autor:
Evrosina I. Isaac, BS, Jacob Hall, MD, Joshua B. Dault, MD, Jeffrey Elbich, MD, Adrienne McGhee, RRA, Emma C. Fields, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 1, Pp 100830- (2022)
Purpose: Transarterial chemoembolization (TACE) in combination with stereotactic body radiation therapy (SBRT) is a promising therapy for patients with hepatocellular carcinoma (HCC). A radiopaque drug-eluting embolic bead used during TACE, called LC
Externí odkaz:
https://doaj.org/article/921ee0afb873494ca27214f9fe65330b
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 1, Pp 100830-(2022)
Advances in Radiation Oncology
Advances in Radiation Oncology
Purpose: Transarterial chemoembolization (TACE) in combination with stereotactic body radiation therapy (SBRT) is a promising therapy for patients with hepatocellular carcinoma (HCC). A radiopaque drug-eluting embolic bead used during TACE, called LC
Autor:
Evrosina I Isaac, Kirstin Drucker, Jennifer M. Rohan, Andrea R. Meisman, Alfonso Floyd, Kathryn L. Behrhorst, Stephanie Violante
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 17, Iss 7, p 2218 (2020)
International Journal of Environmental Research and Public Health
International Journal of Environmental Research and Public Health
Not only do racial and ethnic minority children and adolescents with chronic illness experience disparities in health status and health outcomes, they also experience significant healthcare disparities, including differences in healthcare coverage, a
Autor:
Jordyn Griffin, Tanvi Verma, Caitlin J Cain, Kirstin Drucker, Evrosina I Isaac, Jennifer M. Rohan, Andrea R. Meisman
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 17, Iss 6, p 1956 (2020)
International Journal of Environmental Research and Public Health
International Journal of Environmental Research and Public Health
Previous research suggests that children and adolescents with acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) often have difficulty adhering to complex treatment regimens during the maintenance phase of therapy. Measurement of tre
Autor:
Andrea R. Meisman, Evrosina I Isaac, Jennifer M. Rohan, Linda J. Ewing, Anna C. Muriel, Ernest R. Katz, Urmila Sivagnanalingam, Crista Wetherington Donewar
Publikováno v:
International Journal of Environmental Research and Public Health
Volume 17
Issue 5
International Journal of Environmental Research and Public Health, Vol 17, Iss 5, p 1581 (2020)
Volume 17
Issue 5
International Journal of Environmental Research and Public Health, Vol 17, Iss 5, p 1581 (2020)
Pediatric patients with acute lymphoblastic leukemia and lymphoblastic lymphoma are prescribed a daily oral chemotherapy medication named 6-mercaptopurine. Adherence to this medication is vital for survival and decreased risk for disease relapse. Ada